HIV Infection as a Chronic Disease. Howard Libman, MD Beth Israel Deaconess Medical Center Harvard Medical School

Size: px
Start display at page:

Download "HIV Infection as a Chronic Disease. Howard Libman, MD Beth Israel Deaconess Medical Center Harvard Medical School"

Transcription

1 HIV Infection as a Chronic Disease Howard Libman, MD Beth Israel Deaconess Medical Center Harvard Medical School

2 Role of Primary Care Approximately 50,000 patients are diagnosed with HIV infection annually in the United States, and the number of people living with HIV infection continues to increase Recent guidelines advocate earlier initiation of antiretroviral therapy HIV-infected patients are living longer, and some will develop complications of therapy and other comorbid conditions Along with these patients, the first generation of HIV practitioners is maturing, and many will retire over the next 10 years Future primary care practitioners will have substantial responsibility for the care of this patient population

3 Increasing Prevalence of Persons Living with HIV/AIDS Institute of Medicine, HIV Screening and Access to Care, 2011.

4 Increased HIV Screening of Population Increased Survival of HIV-Infected Patients Increased Number of Patients, Many on Antiretroviral Therapy, Requiring HIV Care Aging of Patient Population and Development of Long-Term Treatment Complications and Comorbid Medical Conditions Need for Increased Primary Care Involvement in HIV Care Decreased Capacity for Provision of Primary Care to HIV-infected Patients Decreased Number of Medical Residents Pursuing Primary Care Inadequate Training of Medical Residents in HIV Outpatient Medicine First Generation of HIV Practitioners Nearing Retirement in Next 10 Years

5 One of the challenges is the emergence of HIV as a chronic medical condition, increasing the complexity of treating HIV-positive individuals Infectious disease specialists may, as a rule, have greater expertise than primary care providers in treating HIV, but increasingly HIV-positive patients require the broader skills of primary care physicians, APRNs, and PAs to address their other health care needs. Institute of Medicine, HIV Screening and Access to Care: Health Care System Capacity for Increased HIV Testing and Provision of Care, 2011.

6 Primary Care Characteristics of HIV Infection HIV infection is chronic, multisystem, and has a spectrum of manifestations Standardized intake, stratified management, and common clinical problems Patient care requires the availability of: nursing support social service subspecialty consultation mental health/addiction professionals clinical trials Multidisciplinary approach is optimal for patients and practitioners

7 Primary Care Practitioner Roles in HIV Care Universal HIV screening and prevention Antiretroviral therapy* and medication adherence Prophylaxis of opportunistic infections Management of comorbid conditions Health care maintenance Immunizations Other HIV-related health care maintenance issues Age- and sex-related health care maintenance issues * Involvement may vary depending upon interest and experience of primary care practitioners and availability of HIV specialists

8 What percentage of diagnosed HIV-infected patients in the US has a suppressed viral load? 1. 77% 2. 51% 3. 45% 4. 35%

9 Overview of HIV Care and Treatment in the United States 100% 80% 60% 40% 20% 0% Diagnosed HIV Patients Linked to Care Remained in Care Prescribed Antiretroviral Therapy Viral Load Suppressed MMWR. 2011;60(47):

10 Long-Term Complications Lipodystrophy syndrome Premature atherosclerosis Lactic acidemia/acidosis Premature bone loss Avascular necrosis of the hips Peripheral neuropathy

11 LDS Clinical Manifestations Lipid metabolism Increased triglycerides Increased cholesterol, LDL, cholesterol/hdl ratio Decreased HDL Glucose metabolism Insulin resistance Glucose intolerance Diabetes mellitus Fat accumulation Increased visceral fat Buffalo hump Lipomatosis Gynecomastia Fat atrophy Face, extremities, buttocks

12 Management of Lipodystrophy Syndrome Hyperlipidemia, insulin resistance Visceral fat accumulation Subcutaneous fat wasting Diet and exercise Switch therapy Older PI atazanavir or NNRTI Statins/fibrates Insulin-sensitizing drugs Diet and exercise Switch therapy Older PI NNRTI Growth hormone or growth hormone releasing factor Cosmetic surgery Switch therapy Older PI NNRTI Insulin-sensitizing drugs Local injection (polylactic acid, calcium hydroxylapatite)

13 HIV Infection and Coronary Artery Disease Incidence of CAD is relatively low but higher than that in HIV-negative patients matched for age and gender Degree to which HIV infection itself, antiretroviral therapy, and traditional risk factors contribute to increased risk in this population is unknown PI class appears to be associated with higher risk of CAD; data regarding abacavir are inconsistent Discontinuation of ART is associated with higher risk of CAD High prevalence of traditional risk factors in this population

14 Major Risk Factors for Coronary Artery Disease Age (men 45 years, women 55 years) High LDL cholesterol (> 160 mg/dl)* Low HDL cholesterol (< 40 mg/dl) Hypertension Family history of premature coronary artery disease (CAD) Diabetes mellitus (DM) Cigarette smoking * With CAD, DM, or multiple risk factors, the desirable level for LDL cholesterol decreases; <100 mg/dl is ideal. Grundy SM et al. JAMA. 2001;285:

15 HIV infection is associated with the following increased percentage risk of acute myocardial infarction beyond that explained by recognized risk factors: 1. 90% 2. 70% 3. 50% 4. 30%

16 The Risk of Coronary Artery Disease in HIV-infected Patients Freiberg MS et al. JAMA Intern Med. 2013;173:

17

18

19

20

21 Premature Bone Loss (1) Osteopenia, osteoporosis, and pathological fractures have been described Osteopenia is asymptomatic, whereas osteoporosis may present with fractures of vertebrae, forearms, or hips Tenofovir, alterations in vitamin D metabolism, and lactic acidemia from NRTI therapy may be responsible for bone loss HIV infection itself may also be a contributing factor

22 Premature Bone Loss (2) Immobility, cigarette smoking, excessive alcohol use, chronic renal disease, hypogonadism, hyperparathyroidism, hyperthyroidism, and steroid use accentuate bone loss Utility of bone densitometry in patients on antiretroviral therapy without other risk factors for premature bone loss is uncertain Calcium and vitamin D should be given in high-risk patients; regular exercise and smoking cessation should be advised

23 Antiretroviral Exposure and Risk of Osteoporotic Fractures Bedino R et al. AIDS. 2012;26:

24 Exposure to Specific Protease Inhibitors and Risk of Osteoporotic Fractures Bedino R et al. AIDS. 2012;26:

25 Screening for Long-Term Complications Glucose Intolerance/Diabetes Mellitus Fasting glucose and/or HgbA1c every 6-12 months Lipid Abnormalities Fasting lipid profile every 6-12 months Body Fat Maldistribution Patient self-report, weight at each visit, and anthropometric measurements (skin fold, waist, and hip) periodically Lactic Acidemia/Acidosis Venous lactic acid level only in symptomatic patients Premature Bone Loss Baseline bone densitometry in post-menopausal women and in men at age 50 Avascular Necrosis of Hips X-rays and MRI only in symptomatic patients

26 Which of the following statements is false about HIV-infected patients over 50 years of age? 1. They present with an earlier stage of disease 2. They constitute 30 percent of HIV-infected patients 3. They are at increased risk of cognitive impairment compared to general population 4. They are at increased risk of common malignancies compared to general population

27 HIV HIV Infection Infection in in the the Older Older Patient Patient (1) (1) Approximately 30% of HIV-infected persons are 50 years of age Limited data on effects of ART in older persons Older persons may be diagnosed later and have more advanced HIV at presentation Medication adherence is generally good

28 Chronic Complications by Age and HIV Status Guaraldi G et al. Clin Infect Dis. 2011;53:

29 HIV Infection in the Older Patient (2) HIV-infected patients accumulate age-related diseases at younger age Neurocognitive disorders and non AIDS-defining cancers are also more prevalent Hypothesis that increased immune activation and long-term chronic inflammation contribute to premature aging in this population Independent risk factors include age, male sex, nadir CD4+ cell count below 200/µL, and antiretroviral therapy

30 Causes of Death in the Modern Era Retrospective study of 39,272 patients in 13 cohorts between In 1597 (85%) of 1876 deaths, cause was identified 49.5% of deaths were AIDS-related, 11.8% were from non-aids malignancies, 8.2% were from non-aids infections, 7.7% were violence- and/or drug-related, 7.0% were from liver disease, and 6.5% were from cardiovascular disease Death rate was higher in patients with history of injection drug use with liver and respiratory diseases responsible for many cases Antiretroviral Therapy Cohort Collaboration. Clin Infect Dis. 2010;50:

31 Figure 1 Antiretroviral Therapy Cohort Collaboration. Clin Infect Dis. 2010;50:

32 Figure 2 Antiretroviral Therapy Cohort Collaboration. Clin Infect Dis. 2010;50:

33 Figure 3 Antiretroviral Therapy Cohort Collaboration. Clin Infect Dis. 2010;50:

34 Summary Primary care practitioners have a significant role in the care of HIVinfected patients Long-term complications associated with HIV infection and its treatment, including coronary artery disease and premature bone loss, will become increasingly common over time HIV-infected patients should be assessed for cardiovascular risk, and modifiable factors should be identified and addressed Baseline bone densitometry should be performed in post-menopausal HIV-infected women and in HIV-infected men > 50 years old Understanding the effect of HIV infection on aging is important in managing older patients with this disease As HIV-infected patients live longer, traditional age-related diseases will account for an increasing percentage of deaths

Primary Care of the HIV-infected Adult: If I Can Do It, You Can Do It

Primary Care of the HIV-infected Adult: If I Can Do It, You Can Do It Primary Care of the HIV-infected Adult: If I Can Do It, You Can Do It Howard Libman, MD Professor of Medicine, Emeritus Harvard Medical School Boston, Massachusetts Learning Objectives After attending

More information

HIV Infection in the Long-term Survivor (Older Patient)

HIV Infection in the Long-term Survivor (Older Patient) HIV Infection in the Long-term Survivor (Older Patient) Howard Libman, MD Professor of Medicine, Harvard Medical School Beth Israel Deaconess Medical Center Boston, Massachusetts Learning Objectives Define

More information

Care of The Older Adult with HIV Infection

Care of The Older Adult with HIV Infection Care of The Older Adult with HIV Infection Howard Libman, MD Professor of Medicine, Harvard Medical School Director, HIV Program, Healthcare Associates Beth Israel Deaconess Medical Center Boston, Massachusetts

More information

Top 10 Things to Know About the Older Patient With HIV Infection

Top 10 Things to Know About the Older Patient With HIV Infection Top 10 Things to Know About the Older Patient With HIV Infection Howard Libman, MD Professor of Medicine, Emeritus Harvard Medical School Beth Israel Deaconess Medical Center Boston, Massachusetts Learning

More information

Primary Care of the HIV-infected Adult: If I Can Do It, You Can Do It

Primary Care of the HIV-infected Adult: If I Can Do It, You Can Do It Primary Care of the HIV-infected Adult: If I Can Do It, You Can Do It Howard Libman, MD Professor of Medicine, Emeritus Harvard Medical School Boston, Massachusetts Learning Objectives After attending

More information

The advent of highly active antiretroviral therapy (ART)

The advent of highly active antiretroviral therapy (ART) treatment complications in HIV Long-Term Treatment Complications in HIV Disease Case Studies and Commentary, Elisa I. Choi, MD, and Howard Libman, MD cme jointly sponsored by Wayne State University School

More information

50+ SHADES OF GREY, AGING WITH HIV

50+ SHADES OF GREY, AGING WITH HIV 50+ SHADES OF GREY, AGING WITH HIV R E B E C C A G L A S S M A N, M D I N S T R U C T O R O F M E D I C I N E, H A R V A R D M E D I C A L S C H O O L MR. C 71 years old Diagnosed with HIV in 1998 at the

More information

ΛΟΙΜΩΞΗ HIV. Ιγνάτιος Οικονομίδης,MD,FESC Β Πανεπιστημιακή Καρδιολογική

ΛΟΙΜΩΞΗ HIV. Ιγνάτιος Οικονομίδης,MD,FESC Β Πανεπιστημιακή Καρδιολογική ΛΟΙΜΩΞΗ HIV Ιγνάτιος Οικονομίδης,MD,FESC Β Πανεπιστημιακή Καρδιολογική Κλινική, Νοσοκομείο «Αττικόν» Infection Acute Myocardial Infarction p er 100,000 HIV/AIDS discharg es 800 700 600 500 400 300 200

More information

Prevalence of Comorbidities among HIV-positive patients in Taiwan

Prevalence of Comorbidities among HIV-positive patients in Taiwan Prevalence of Comorbidities among HIV-positive patients in Taiwan Chien-Ching Hung, MD, PhD Department of Internal Medicine National Taiwan University Hospital, Taipei, Taiwan % of participants Comorbidity

More information

Situación actual de los pacientes VIH+ Esteban Martínez Hospital Clínic Barcelona

Situación actual de los pacientes VIH+ Esteban Martínez Hospital Clínic Barcelona Situación actual de los pacientes VIH+ Esteban Martínez Hospital Clínic Barcelona Mortality per 1 patient-years HIV infection has changed from a fatal disease into a chronic condition This means long-term

More information

Endocrinopathy and Leukocyte Telomere Length in HIV+ Individuals in the CARMA Cohort

Endocrinopathy and Leukocyte Telomere Length in HIV+ Individuals in the CARMA Cohort Endocrinopathy and Leukocyte Telomere Length in HIV+ Individuals in the CARMA Cohort Kristen M. Sokalski, Alice Mai, Jackson Chu, Hélène Côté, Evelyn J. Maan, Arianne Albert, Neora Pick, Deborah Money,

More information

Fat redistribution on ARVs: dogma versus data

Fat redistribution on ARVs: dogma versus data Fat redistribution on ARVs: dogma versus data Gary Maartens Division of Clinical Pharmacology UNIVERSITY OF CAPE TOWN IYUNIVESITHI YASEKAPA UNIVERSITEIT VAN KAAPSTAD Half of what we are going to teach

More information

Future challenges for clinical care of an ageing population infected with HIV: a geriatric -HIV modelling study

Future challenges for clinical care of an ageing population infected with HIV: a geriatric -HIV modelling study Future challenges for clinical care of an ageing population infected with HIV: a geriatric -HIV modelling study Guaraldi G 1, De Francesco D 2, Malagoli A 1, Theou O 3, Zona S 1, Carli F 1, Dolci G 1,

More information

Hans Strijdom SA Heart Meeting November 2017

Hans Strijdom SA Heart Meeting November 2017 Hans Strijdom SA Heart Meeting November 2017 HIV-infection and ART, but not high sensitivity CRP, are associated with markers of vascular function: Results from the Western Cape cohort of the EndoAfrica

More information

Ischemic Cardiovascular Disease in Persons with Human Immunodeficiency Virus Infection

Ischemic Cardiovascular Disease in Persons with Human Immunodeficiency Virus Infection HIV/AIDS MAJOR ARTICLE Ischemic Cardiovascular Disease in Persons with Human Immunodeficiency Virus Infection Max H. David, 1,3 Richard Hornung, 2 and Carl J. Fichtenbaum 1 1 Department of Medicine, Division

More information

TOXICITY, TOLERABILITY, AND ADHERENCE TO THERAPY

TOXICITY, TOLERABILITY, AND ADHERENCE TO THERAPY SAFETY AND TOLERABILITY OF CURRENTLY AVAILABLE ANTIRETROVIRAL AGENTS * Esteban Martinez, MD, PhD ABSTRACT Safety and tolerability are important factors to consider when instituting or modifying therapy

More information

Clinical Recommendations: Patients with Periodontitis

Clinical Recommendations: Patients with Periodontitis The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: Periodontitis and Atherosclerotic Cardiovascular Disease. Friedewald VE, Kornman KS, Beck JD, et al. J Periodontol 2009;

More information

Chapter 18. Diet and Health

Chapter 18. Diet and Health Chapter 18 Diet and Health Risk Factors and Chronic Diseases Interrelationships among Chronic Diseases Chronic Disease Heart Disease and Stroke Hypertension Cancer Diabetes The Formation of Plaques in

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Briefing paper QOF indicator area: Primary prevention of CVD Potential output:

More information

Diabetes and Heart Disease. Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center

Diabetes and Heart Disease. Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center Diabetes and Heart Disease Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center No conflicts of interest or financial relationships to disclose. 2 What s the problem??

More information

PIs are the real world answer for the chronic patient s management. Giovanni Guaraldi

PIs are the real world answer for the chronic patient s management. Giovanni Guaraldi PIs are the real world answer for the chronic patient s management Giovanni Guaraldi HIV MEDICATION TOXICITY Ageing with HIV: The clinical consequences AGEING Heart disease Kidney disease Liver disease

More information

2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary

2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary 2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease Becky McKibben, MPH; Seth

More information

1. Which one of the following patients does not need to be screened for hyperlipidemia:

1. Which one of the following patients does not need to be screened for hyperlipidemia: Questions: 1. Which one of the following patients does not need to be screened for hyperlipidemia: a) Diabetes mellitus b) Hypertension c) Family history of premature coronary disease (first degree relatives:

More information

Cardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003

Cardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003 Authorized By: Medical Management Guideline Committee Approval Date: 12/13/01 Revision Date: 12/11/03 Beta-Blockers Nitrates Calcium Channel Blockers MEDICATIONS Indicated in post-mi, unstable angina,

More information

Diabetes Mellitus: A Cardiovascular Disease

Diabetes Mellitus: A Cardiovascular Disease Diabetes Mellitus: A Cardiovascular Disease Nestoras Mathioudakis, M.D. Assistant Professor of Medicine Division of Endocrinology, Diabetes, & Metabolism September 30, 2013 1 The ABCs of cardiovascular

More information

Nutrition and HIV/AIDS: A Training Manual Session 3

Nutrition and HIV/AIDS: A Training Manual Session 3 Nutrition and HIV/AIDS: A Training Manual Session 3 Purpose To provide general nutrition and dietary guidelines to mitigate the effects of HIV on nutrition and reduce the progression of HIV/AIDS morbidity,

More information

Autonomic neuropathy

Autonomic neuropathy 3. Neuropathy Autonomic neuropathy MACROVASCULAR: Accelerated atherosclerosis Coronary artery disease IHD / MI Cerebrovascular disease CVA Peripheral vascular disease gangrene / amputations NB: association

More information

OCHSNER PHYSICIAN PARTNERS. PQRS Measures by Specialty (FINAL)

OCHSNER PHYSICIAN PARTNERS. PQRS Measures by Specialty (FINAL) OCHSNER PHYSICIAN PARTNERS PQRS Measures by Specialty (FINAL) Allergy and Immunology 2. Asthma: Pharmacologic Therapy for Persistent Asthma - Ambulatory Care Setting (PQRS 53) 3. Patients aged 18 years

More information

Real Life Experience of Dolutegravir and Lamivudine Dual Therapy As a Switching Regimen in HIVTR Cohort

Real Life Experience of Dolutegravir and Lamivudine Dual Therapy As a Switching Regimen in HIVTR Cohort Real Life Experience of Dolutegravir and Lamivudine Dual Therapy As a Switching Regimen in HIVTR Cohort Yagci-Caglayik D 1, Gokengin D 2, Inan A 3, Ozkan-Ozdemir H 4, Inan D 5, Akbulut A 6, Korten V 1,

More information

Primary Care for Patients with HIV/AIDS What makes it different?

Primary Care for Patients with HIV/AIDS What makes it different? HIV and AIDS Management for the Primary Care Provider Carl B. LeBuhn, MD October 4 th, 009 Primary Care for Patients with HIV/AIDS What makes it different? Drug-drug interactions relatively more prevalent

More information

HIV Update For the Internist

HIV Update For the Internist HIV Update For the Internist Disclosures I declare that I have received no incentives, financial or otherwise, from pharmaceutical or biomedical companies relevant to the content of this talk. As an Infectious

More information

Optimizing Health While Aging with HIV

Optimizing Health While Aging with HIV Slide 1 Optimizing Health While Aging with HIV Todd T. Brown, MD, PhD Division of Endocrinology and Metabolism Johns Hopkins University Unfortunately, We are Not Slide 2 Immortal But How Do We Want to

More information

Preclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD

Preclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD Preclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD 1 Preclinical? No symptoms No physical findings No diagnostic ECG findings No chest X-ray X findings No diagnostic events 2

More information

Endothelial dysfunction and subclinical atherosclerosis in HIV/HCV- coinfected patients in the Lower Silesia Region, Poland

Endothelial dysfunction and subclinical atherosclerosis in HIV/HCV- coinfected patients in the Lower Silesia Region, Poland Endothelial dysfunction and subclinical atherosclerosis in HIV/HCV- coinfected patients in the Lower Silesia Region, Poland Katarzyna Barska 1,2, Wiesława Kwiatkowska 1,2, Brygida Knysz 1,3, Justyna Drelichowska

More information

Natural history of HIV Infection

Natural history of HIV Infection HIV in Primary Care Joint RCGP/BHIVA Multidisciplinary Conference Dr Ian Williams University College London Medical School Friday 25 January 2013, Royal College of General Practitioners, London HIV Treatment

More information

To interrupt or not to interrupt Are we SMART enough?

To interrupt or not to interrupt Are we SMART enough? SMART To interrupt or not to interrupt Are we SMART enough? highly active antiretroviral therapy 5 1996 1997 10 25 43 45 35 metabolism 50 copies/ml lipodystrophy [fat redistribution syndrome] lactic acidosis

More information

LDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC

LDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC Am J Cardiol (2004);94:729-32 Relation of degree of physical activity to coronary artery calcium score in asymptomatic individuals with multiple metabolic risk factors M. Y. Desai, et al. Ciccarone Preventive

More information

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION 2 Hyperlipidemia Andrew Cohen, MD and Neil S. Skolnik, MD CONTENTS INTRODUCTION RISK CATEGORIES AND TARGET LDL-CHOLESTEROL TREATMENT OF LDL-CHOLESTEROL SPECIAL CONSIDERATIONS OLDER AND YOUNGER ADULTS ADDITIONAL

More information

Osteoporosis/Fracture Prevention

Osteoporosis/Fracture Prevention Osteoporosis/Fracture Prevention NATIONAL GUIDELINE SUMMARY This guideline was developed using an evidence-based methodology by the KP National Osteoporosis/Fracture Prevention Guideline Development Team

More information

BHIVA Best of CROI Feedback Meetings. London Birmingham North West England Cardiff Gateshead Edinburgh

BHIVA Best of CROI Feedback Meetings. London Birmingham North West England Cardiff Gateshead Edinburgh BHIVA Best of CROI Feedback Meetings London Birmingham North West England Cardiff Gateshead Edinburgh BHIVA Best of CROI Feedback Meetings 2010 COMPLICATIONS OF HIV DISEASE AND TREATMENT Overview Cardiovascular

More information

Didactic Series. Lipohypertrophy in HIV

Didactic Series. Lipohypertrophy in HIV Didactic Series Lipohypertrophy in HIV Daniel Lee, MD Clinical Professor of Medicine UCSD Medical Center Owen Clinic August 14th, 2014 ACCREDITATION STATEMENT: University of California, San Diego School

More information

HIV and Bone Disease: Through Thick and Thin! Pablo Tebas, MD

HIV and Bone Disease: Through Thick and Thin! Pablo Tebas, MD HIV and Bone Disease: Through Thick and Thin! Pablo Tebas, MD April 30 th, 2016 Disclosures I serve in an adjudication panel in a VZV vaccine study (Glaxo) I consult for Merck My research is supported

More information

HIGH BURDEN OF METABOLIC COMORBIDITIES IN A CITYWIDE COHORT OF HIV OUTPATIENTS

HIGH BURDEN OF METABOLIC COMORBIDITIES IN A CITYWIDE COHORT OF HIV OUTPATIENTS HIGH BURDEN OF METABOLIC COMORBIDITIES IN A CITYWIDE COHORT OF HIV OUTPATIENTS Evolving Health Care Needs of People Aging with HIV in Washington, DC Matthew E. Levy 1, Alan E. Greenberg 1, Rachel Hart

More information

An Introduction to HIV Shared Care for GPs

An Introduction to HIV Shared Care for GPs An Introduction to HIV Shared Care for GPs Managing HIV as a chronic condition With effective antiretroviral therapy (ART), HIV infection is now considered a chronic condition and people living with HIV

More information

Kathryn M. Rexrode, MD, MPH. Assistant Professor. Division of Preventive Medicine Brigham and Women s s Hospital Harvard Medical School

Kathryn M. Rexrode, MD, MPH. Assistant Professor. Division of Preventive Medicine Brigham and Women s s Hospital Harvard Medical School Update: Hormones and Cardiovascular Disease in Women Kathryn M. Rexrode, MD, MPH Assistant Professor Division of Preventive Medicine Brigham and Women s s Hospital Harvard Medical School Overview Review

More information

CLINICAL PRACTICE EVALUATION I: MEDICAL RECORD REVIEW (Adult Patient Population)

CLINICAL PRACTICE EVALUATION I: MEDICAL RECORD REVIEW (Adult Patient Population) Diplomate: CLINICAL PRACTICE EVALUATION I: MEDICAL RECORD REVIEW (Adult Patient Population) A. RECORD IDENTIFIER INFORMATION 1. Date medical record reviewed (mm/dd/year) / / 2. Patient identifier: 3. Date

More information

Comorbidities: a moving area. Paul De Munter ARC Leuven BREACH

Comorbidities: a moving area. Paul De Munter ARC Leuven BREACH Comorbidities: a moving area Paul De Munter ARC Leuven BREACH 27-11-2015 Contents Introduction Comorbidities Cardiovascular disease and lipids Diabetes mellitus Hepatitis C Frailty Conclusion Introduction

More information

NURSING CARE. HIV-Infected INMATE. of the. METABOLIC COMPLICATIONS of HIV. Albany Medical Center. Module 9 S U M M E R / F A L L

NURSING CARE. HIV-Infected INMATE. of the. METABOLIC COMPLICATIONS of HIV. Albany Medical Center. Module 9 S U M M E R / F A L L NURSING CARE of the HIV-Infected INMATE METABOLIC COMPLICATIONS of HIV Module 9 S U M M E R / F A L L 0 0 7 Albany Medical Center This learning activity is co-provided by The Albany Medical Center Hospital

More information

Frailty and age are independently associated with patterns of HIV antiretroviral use in a clinical setting. Giovanni Guaraldi

Frailty and age are independently associated with patterns of HIV antiretroviral use in a clinical setting. Giovanni Guaraldi Frailty and age are independently associated with patterns of HIV antiretroviral use in a clinical setting Giovanni Guaraldi Potential conflicts of interest Research funding: Jansen, Gilead, MSD, BMS Consultancies:

More information

The Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk

The Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk The Metabolic Syndrome Update 2018 Marc Cornier, M.D. Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine

More information

Update on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines

Update on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines Update on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines Paul Mahoney, MD Sentara Cardiology Specialists Lipid Management in Cardiovascular Disease

More information

Aging and HIV: Living Life with Silver Hair

Aging and HIV: Living Life with Silver Hair Georgia Southern University Digital Commons@Georgia Southern 6th Annual Rural HIV Research and Training Conference Sep 21st, 4:30 PM - 5:15 PM Aging and HIV: Living Life with Silver Hair Barbara J. Blake

More information

Diabetes and Heart Disease

Diabetes and Heart Disease Diabetes and Heart Disease Sarah Alexander, MD Assistant Professor of Medicine Division of Cardiology Rush University Medical Center 2/8/2017 Rush is a not-for-profit health care, education and research

More information

Diabetes Mellitus in Older Adults. Presenter Disclosure Information

Diabetes Mellitus in Older Adults. Presenter Disclosure Information Diabetes Mellitus in Older Adults Medha Munshi, M.D. Joslin Diabetes Center Beth Israel Deaconess Medical Center Harvard Medical School Presenter Disclosure Information Medha Munshi Research grant from

More information

HIV and your Bones Osteopenia and Osteoporosis

HIV and your Bones Osteopenia and Osteoporosis Osteopenia and Osteoporosis Background information For reasons not yet fully understood, higher rates of bone disease are starting to be seen in people living with HIV. These bone diseases include osteopenia

More information

HIV & Aging: Evolving Clinical Considerations in the New Millennium

HIV & Aging: Evolving Clinical Considerations in the New Millennium HIV & Aging: Evolving Clinical Considerations in the New Millennium Julian Falutz, MD, FRCP (C) Director, HIV Metabolic Clinic Immunodeficiency Treatment Centre Senior Physician Division of Geriatrics

More information

Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY

Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY MCC-006 POST GRADUATE DIPLOMA IN CLINICAL CARDIOLOGY (PGDCC) 00269 Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY Time : 2 hours Maximum Marks : 60 Note : There will be multiple

More information

Coronary Artery Disease Clinical Practice Guidelines

Coronary Artery Disease Clinical Practice Guidelines Coronary Artery Disease Clinical Practice Guidelines Guidelines are systematically developed statements to assist patients and providers in choosing appropriate healthcare for specific clinical conditions.

More information

The impact of antiretroviral drugs on Cardiovascular Health

The impact of antiretroviral drugs on Cardiovascular Health The impact of antiretroviral drugs on Cardiovascular Health José López-Sendón Hospital Universitario La Paz. IdiPaz Madrid. Spain Research grants and honoraria from (research committees, clinical trials,

More information

Learning Objectives. ! Students will become familiar with the 3 treatment solutions for osteoporosis. ! Students should be able to define osteoporosis

Learning Objectives. ! Students will become familiar with the 3 treatment solutions for osteoporosis. ! Students should be able to define osteoporosis Learning Objectives! Students should be able to define osteoporosis! Students should be able to identify some risk factors of osteoporosis! Students should be able to identify some of the people in the

More information

3TC (lamivudine, Epivir)

3TC (lamivudine, Epivir) FACTSHEET 3TC (lamivudine, Epivir) Summary 3TC is a type of antiretroviral drug called a nucleoside analogue (or nuke ). 3TC can cause nausea, headache, diarrhea, vomiting and weakness; however, it causes

More information

Corporate Health Screening

Corporate Health Screening Corporate Health Screening What should I look out for? Presented by: Dr Wee Wei Keong Director Health for Life Programme WHAT IS HEALTH SCREENING? Tests/procedures carried out to detect a condition/disease

More information

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Metabolic Syndrome Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Disclosure No conflict of interest No financial disclosure Does This Patient Have Metabolic Syndrome? 1. Yes 2. No Does This Patient

More information

Osteoporosis: fragility fracture risk. Costing report. Implementing NICE guidance

Osteoporosis: fragility fracture risk. Costing report. Implementing NICE guidance Osteoporosis: fragility fracture risk Costing report Implementing NICE guidance August 2012 NICE clinical guideline 146 1 of 15 This costing report accompanies the clinical guideline: Osteoporosis: assessing

More information

Metabolic Syndrome and Chronic Kidney Disease

Metabolic Syndrome and Chronic Kidney Disease Metabolic Syndrome and Chronic Kidney Disease Definition of Metabolic Syndrome National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III Abdominal obesity, defined as a waist circumference

More information

Risk of Fractures Following Cataract Surgery in Medicare Beneficiaries

Risk of Fractures Following Cataract Surgery in Medicare Beneficiaries Risk of Fractures Following Cataract Surgery in Medicare Beneficiaries Victoria L. Tseng, MD, Fei Yu, PhD, Flora Lum, MD, Anne L. Coleman, MD, PhD JAMA. 2012;308(5):493-501 Background Visual impairment

More information

ANTIRETROVIRAL TOXICITY Strategies for prevention and treatment

ANTIRETROVIRAL TOXICITY Strategies for prevention and treatment ANTIRETROVIRAL TOXICITY Strategies for prevention and treatment Francisco Antunes Professor da Faculdade de Medicina da Universidade de Lisboa e Director do Serviço de Doenças Infecciosas do Hospital de

More information

Late Effects of Transplants: Lessons learned and strategies to improve the health of the HCT survivor

Late Effects of Transplants: Lessons learned and strategies to improve the health of the HCT survivor Late Effects of Transplants: Lessons learned and strategies to improve the health of the HCT survivor Saro Armenian, DO, MPH Associate Professor, Departments of Pediatrics and Population Sciences Director,

More information

Research Article Metabolic Disorders in HIV-Infected Adolescents Receiving Protease Inhibitors

Research Article Metabolic Disorders in HIV-Infected Adolescents Receiving Protease Inhibitors Hindawi BioMed Research International Volume 2017, Article ID 7481597, 14 pages https://doi.org/10.1155/2017/7481597 Research Article Metabolic Disorders in HIV-Infected Adolescents Receiving Protease

More information

Lipoatrophy and Fat Accumulation in HIV-Infected Adults

Lipoatrophy and Fat Accumulation in HIV-Infected Adults Switch to a PI-Containing/NRTI-Sparing regimen (LPVr/EFV) increases appendicular fat content and serum lipid levels without affecting glucose metabolism or bone mineral density. The results of a prospective

More information

Lipids Testing

Lipids Testing Previously Listed as Edit 12 190.23 - Lipids Testing Lipoproteins are a class of heterogeneous particles of varying sizes and densities containing lipid and protein. These lipoproteins include cholesterol

More information

DYSLIPIDEMIA RECOMMENDATIONS

DYSLIPIDEMIA RECOMMENDATIONS DYSLIPIDEMIA RECOMMENDATIONS Α. DIAGNOSIS Recommendation 1 INITIAL LIPID PROFILING (Level of evidence II) It is recommended to GPs and other PHC Physicians to assess the lipid profile {total cholesterol

More information

Risk Factors for Heart Disease

Risk Factors for Heart Disease Risk Factors for Heart Disease Risk Factors we cannot change (Age, Gender, Family History) Risk Factors we can change (modifiable) Smoking Blood pressure Cholesterol Diabetes Inactivity Overweight Stress

More information

THE EFFECT OF VITAMIN-C THERAPY ON HYPERGLYCEMIA, HYPERLIPIDEMIA AND NON HIGH DENSITY LIPOPROTEIN LEVEL IN TYPE 2 DIABETES

THE EFFECT OF VITAMIN-C THERAPY ON HYPERGLYCEMIA, HYPERLIPIDEMIA AND NON HIGH DENSITY LIPOPROTEIN LEVEL IN TYPE 2 DIABETES Int. J. LifeSc. Bt & Pharm. Res. 2013 Varikasuvu Seshadri Reddy et al., 2013 Review Article ISSN 2250-3137 www.ijlbpr.com Vol. 2, No. 1, January 2013 2013 IJLBPR. All Rights Reserved THE EFFECT OF VITAMIN-C

More information

The Guidelines Guide: Routine Adult Screening Created March 2009 by Alana Benjamin, MD Last updated: June 29 th, 2010

The Guidelines Guide: Routine Adult Screening Created March 2009 by Alana Benjamin, MD Last updated: June 29 th, 2010 The Guidelines Guide: Routine Adult Screening Created March 2009 by Alana Benjamin, MD Last updated: June 29 th, 2010 Table of Contents Topic Page Introduction 2 Abbreviations 2 USPSTF Grades of Recommendations

More information

Patient: Shawn Baker March 06, 2018

Patient: Shawn Baker March 06, 2018 Mr. Shawn Baker Dear Participant: Our team at SpecialtyHealth has received your lab work and the results have been reviewed. In this letter you will find a summary of the results along with numerous charts

More information

JAIDS Journal of Acquired Immune Deficiency Syndromes 31: Lippincott Williams & Wilkins, Inc., Philadelphia. Rapid Communications

JAIDS Journal of Acquired Immune Deficiency Syndromes 31: Lippincott Williams & Wilkins, Inc., Philadelphia. Rapid Communications JAIDS Journal of Acquired Immune Deficiency Syndromes 31:257 275 2002 Lippincott Williams & Wilkins, Inc., Philadelphia Rapid Communications Management of Metabolic Complications Associated With Antiretroviral

More information

Cardiovascular Disease Risk Factors:

Cardiovascular Disease Risk Factors: Cardiovascular Disease Risk Factors: Risk factors are traits or habits that increase a person's chances of having cardiovascular disease. Some risk factors can be changed. These risk factors are high blood

More information

Common Repatha Documentation Requirements for Patients With Primary Hyperlipidemia and Established CVD 1,2

Common Repatha Documentation Requirements for Patients With Primary Hyperlipidemia and Established CVD 1,2 Established CVD Common Repatha Documentation Requirements for Patients With Primary Hyperlipidemia and Established CVD 1,2 Primary and Secondary Diagnosis Codes Primary Diagnosis: Primary hyperlipidemia

More information

Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV Dyslipidemia: Post- Hoc Analysis of the INTREPID Trial Based on the Independent CHD Risk Factor for Age

Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV Dyslipidemia: Post- Hoc Analysis of the INTREPID Trial Based on the Independent CHD Risk Factor for Age Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV Dyslipidemia: Post- Hoc Analysis of the INTREPID Trial Based on the Independent CHD Risk Factor for Age Craig A. Sponseller, Masaya Tanahashi, Hideki Suganami,

More information

POST-EXPOSURE PROPHYLAXIS, PRE-EXPOSURE PROPHYLAXIS, & TREATMENT OF HIV

POST-EXPOSURE PROPHYLAXIS, PRE-EXPOSURE PROPHYLAXIS, & TREATMENT OF HIV POST-EXPOSURE PROPHYLAXIS, PRE-EXPOSURE PROPHYLAXIS, & TREATMENT OF HIV DISCLOSURE Relevant relationships with commercial entities none Potential for conflicts of interest within this presentation none

More information

How would you manage Ms. Gold

How would you manage Ms. Gold How would you manage Ms. Gold 32 yo Asian woman with dyslipidemia Current medications: Simvastatin 20mg QD Most recent lipid profile: TC = 246, TG = 100, LDL = 176, HDL = 50 What about Mr. Williams? 56

More information

Osteoporosis challenges

Osteoporosis challenges Osteoporosis challenges Osteoporosis challenges Who should have a fracture risk assessment? Who to treat? Drugs, holidays and unusual adverse effects Fracture liaison service? The size of the problem 1

More information

OSTEOPOROSIS: PREVENTION AND MANAGEMENT

OSTEOPOROSIS: PREVENTION AND MANAGEMENT OSTEOPOROSIS: OVERVIEW OSTEOPOROSIS: PREVENTION AND MANAGEMENT Judith Walsh, MD, MPH Departments of Medicine and Epidemiology and Biostatistics UCSF Definitions Key Risk factors Screening and Monitoring

More information

Disclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease

Disclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease Disclosures Diabetes and Cardiovascular Risk Management Tony Hampton, MD, MBA Medical Director Advocate Aurora Operating System Advocate Aurora Healthcare Downers Grove, IL No conflicts or disclosures

More information

Structured Treatment Interruption in HIV Positive Patients. Leah Jackson, BScPhm Pharmacy Resident HIV Rotation January 23, 2007

Structured Treatment Interruption in HIV Positive Patients. Leah Jackson, BScPhm Pharmacy Resident HIV Rotation January 23, 2007 Structured Treatment Interruption in HIV Positive Patients Leah Jackson, BScPhm Pharmacy Resident HIV Rotation January 23, 2007 Objectives To become re-acquainted with the basics of HAART for HIV infection

More information

Metabolic Syndrome.

Metabolic Syndrome. www.bmiweightloss.com.au What is the metabolic syndrome? The was first described in 1988 by Gerald Reavson It was originally described as the clustering of four conditions These conditions when present

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: : assessing the risk of fragility fracture bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new

More information

Aromatase Inhibitors & Osteoporosis

Aromatase Inhibitors & Osteoporosis Aromatase Inhibitors & Osteoporosis Miss Sarah Horn Consultant Oncoplastic Breast Surgeon April 2018 Aims Role of Aromatase Inhibitors (AI) in breast cancer treatment AI s effects on bone health Bone health

More information

Supplemental Table S2: Subgroup analysis for IL-6 with BMI in 3 groups

Supplemental Table S2: Subgroup analysis for IL-6 with BMI in 3 groups Supplemental Table S1: Unadjusted and Adjusted Hazard Ratios for Diabetes Associated with Baseline Factors Considered in Model 3 SMART Participants Only Unadjusted Adjusted* Baseline p-value p-value Covariate

More information

Late Effects of Transplants: Lessons learned and strategies to improve the health of the HCT survivor

Late Effects of Transplants: Lessons learned and strategies to improve the health of the HCT survivor Late Effects of Transplants: Lessons learned and strategies to improve the health of the HCT survivor Saro Armenian, DO, MPH Associate Professor, Departments of Pediatrics and Population Sciences Director,

More information

Wellness: Concepts and Applications 8 th Edition Anspaugh, Hamrick, Rosato

Wellness: Concepts and Applications 8 th Edition Anspaugh, Hamrick, Rosato Wellness: Concepts and Applications 8 th Edition Anspaugh, Hamrick, Rosato Preventing Cardiovascular Disease Chapter 2 Cardiovascular Disease the leading cause of death in the U.S. 35.3% of all deaths

More information

What is Diabetes Mellitus?

What is Diabetes Mellitus? Normal Glucose Metabolism What is Diabetes Mellitus? When the amount of glucose in the blood increases, After a meal, it triggers the release of the hormone insulin from the pancreas. Insulin stimulates

More information

Impact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients

Impact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients 2012 International Conference on Life Science and Engineering IPCBEE vol.45 (2012) (2012) IACSIT Press, Singapore DOI: 10.7763/IPCBEE. 2012. V45. 14 Impact of Physical Activity on Metabolic Change in Type

More information

Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk

Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk Metabolic Syndrome Update 21 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes University of Colorado Denver Denver Health Medical Center The Metabolic

More information

1. E-learning: NHIVNA HIV modules on the NHIVNA website

1. E-learning: NHIVNA HIV modules on the NHIVNA website Vers Jan 18 E LEARNING sessions to complete for STIF NHIVNA Core Competency 1. E-learning: NHIVNA HIV modules on the NHIVNA website http://www.nhivna.org/nhivna-hiv-nursing-modules.aspx The NHIVNA HIV

More information

LLL Session - Nutrition support in diabetes and dyslipidemia. Dyslipidemia: targeting the management of cardiovascular risk factors. M.

LLL Session - Nutrition support in diabetes and dyslipidemia. Dyslipidemia: targeting the management of cardiovascular risk factors. M. ESPEN Congress Leipzig 2013 LLL Session - Nutrition support in diabetes and dyslipidemia Dyslipidemia: targeting the management of cardiovascular risk factors M. Leon Sanz (ES) Dyslipidemia: Targeting

More information

SCIENTIFIC STUDY REPORT

SCIENTIFIC STUDY REPORT PAGE 1 18-NOV-2016 SCIENTIFIC STUDY REPORT Study Title: Real-Life Effectiveness and Care Patterns of Diabetes Management The RECAP-DM Study 1 EXECUTIVE SUMMARY Introduction: Despite the well-established

More information

Plasma fibrinogen level, BMI and lipid profile in type 2 diabetes mellitus with hypertension

Plasma fibrinogen level, BMI and lipid profile in type 2 diabetes mellitus with hypertension World Journal of Pharmaceutical Sciences ISSN (Print): 2321-3310; ISSN (Online): 2321-3086 Published by Atom and Cell Publishers All Rights Reserved Available online at: http://www.wjpsonline.org/ Original

More information

Metformin should be considered in all patients with type 2 diabetes unless contra-indicated

Metformin should be considered in all patients with type 2 diabetes unless contra-indicated November 2001 N P S National Prescribing Service Limited PPR fifteen Prescribing Practice Review PPR Managing type 2 diabetes For General Practice Key messages Metformin should be considered in all patients

More information